Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Adenocarcinoma, Bronchiolo-Alveolar 2Adenocarcinoma of Lung 2Wilms Tumor 1Salivary Gland Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Extensive Stage Small Cell Lung Carcinoma 1

Interventions

enzalutamide 28Magnetic Resonance Spectroscopy 28Specimen Handling 21apalutamide 18Androgen Antagonists 16Abiraterone Acetate 15Prednisone 14Radiosurgery 13abiraterone 12Docetaxel 12Radiotherapy 11Biopsy 10darolutamide 9Nivolumab 8Radiation 7Pluvicto 72-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 7niraparib 6luprolide acetate gel depot 6cabazitaxel 6Surveys and Questionnaires 6gallium 68 PSMA-11 5bicalutamide 5Radiotherapy, Intensity-Modulated 5Lutetium-177 5Leuprolide 5Gonadotropin-Releasing Hormone 5radium Ra 223 dichloride 4pembrolizumab 4olaparib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Radiotherapy, Conformal × 30 days × Clear all
NCT04423211 2026-05-15

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Eastern Cooperative Oncology Group

Phase 3 Recruiting
804 enrolled
Genitourinary

Prostatic Neoplasms

NCT01368588 2026-05-08

Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Radiation Therapy Oncology Group

Phase 3 Active not recruiting
2,590 enrolled 18 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡